PT Kimia Farma Tbk (ISX:KAEF) Long-Term Debt: Rp6,315,472 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ISX:KAEF PT Kimia Farma Tbk ISX:KAEF
58 GF Score
Price Rp454.00
GF Value Rp580.01
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is PT Kimia Farma Tbk Long-Term Debt?

PT Kimia Farma Tbk ISX:KAEF -0.87% 58 Long-Term Debt is Rp6,315,472 Mil as of Jun. 2026. GuruFocus rates ISX:KAEF with a GF Score™ of 58/100 and a GF Value™ of Rp580.01 (Modestly Undervalued). The stock has 4 warning signs investors should review.

PT Kimia Farma Tbk's Long-Term Debt for the quarter that ended in Jun. 2026 was Rp6,315,472 Mil.

PT Kimia Farma Tbk's quarterly Long-Term Debt increased from Dec. 2025 (Rp3,384,003 Mil) to Mar. 2026 (Rp4,421,671 Mil) and increased from Mar. 2026 (Rp4,421,671 Mil) to Jun. 2026 (Rp6,315,472 Mil).

PT Kimia Farma Tbk's annual Long-Term Debt increased from Dec. 2023 (Rp730,404 Mil) to Dec. 2024 (Rp2,653,969 Mil) and increased from Dec. 2024 (Rp2,653,969 Mil) to Dec. 2025 (Rp3,384,003 Mil).

PT Kimia Farma Tbk  (ISX:KAEF) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

PT Kimia Farma Tbk Long-Term Debt Related Terms

PT Kimia Farma Tbk Long-Term Debt Historical Data

* Premium members only.

The historical data trend for PT Kimia Farma Tbk's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PT Kimia Farma Tbk Long-Term Debt Chart

PT Kimia Farma Tbk Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Long-Term Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3,209,731.47 1,666,077.91 730,403.81 2,653,968.99 3,384,002.66

PT Kimia Farma Tbk Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Long-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3,826,779.60 3,826,945.91 3,384,002.66 4,421,671.45 6,315,471.94
ISX:KAEF
58GF Score
PT Kimia Farma Tbk ISX:KAEF
Long-Term Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Long-Term Debt →
What does a Long-Term Debt of Rp6,315,472 Mil mean?
PT Kimia Farma Tbk (ISX:KAEF) has a Long-Term Debt of Rp6,315,472 Mil as of Jun. 2026.
Is PT Kimia Farma Tbk's Long-Term Debt too high?
PT Kimia Farma Tbk's current Long-Term Debt is Rp6,315,472 Mil. Overall, PT Kimia Farma Tbk has a GF Score™ of 58/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does PT Kimia Farma Tbk's Long-Term Debt compare to MCK and COR?
PT Kimia Farma Tbk's Long-Term Debt of Rp6,315,472 Mil can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Long-Term Debt for a Medical Distribution company?
A good Long-Term Debt depends on the Medical Distribution industry context. However, Long-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Long-Term Debt mean?
A high Long-Term Debt can signal that a stock is expensive relative to its fundamentals. PT Kimia Farma Tbk's current Long-Term Debt is Rp6,315,472 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Kimia Farma Tbk stock overvalued right now?
Based on GuruFocus' analysis, PT Kimia Farma Tbk (ISX:KAEF) is currently considered Modestly Undervalued. The stock's GF Value™ is Rp580.01, compared to a current price of Rp454.00 — trading 21.7% below its estimated fair value. The current Long-Term Debt is Rp6,315,472 Mil. PT Kimia Farma Tbk's overall GF Score™ is 58/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Long-Term Debt calculated?
Long-Term Debt is calculated from a company's financial statements. For PT Kimia Farma Tbk (ISX:KAEF), the current Long-Term Debt is Rp6,315,472 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is PT Kimia Farma Tbk (ISX:KAEF) Overvalued in 2026?

Based on GuruFocus' analysis, PT Kimia Farma Tbk stock appears to be undervalued. The current stock price of Rp454.00 is trading 21.7% below its estimated GF Value™ of Rp580.01. GuruFocus considers PT Kimia Farma Tbk to be Modestly Undervalued.

Key valuation signals for ISX:KAEF:

  • Long-Term Debt: Rp6,315,472 Mil
  • GF Value™: Rp580.01 vs. price of Rp454.00 (21.7% below fair value)
  • GF Score™: 58/100 with 4 warning signs

No single metric tells the full story. See the ISX:KAEF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

PT Kimia Farma Tbk Business Description

Address Jalan Veteran No. 9 Gambir, Jakarta Pusat, Jakarta, IDN, 10110
PT Kimia Farma Tbk is an Indonesia-based company engaged in the production and distribution of healthcare products. It operates through the following segments: Manufacture, Distribution, Retail, and Others. The company provides its products in categories including OTC & Herb, Ethical, Cosmetic, Generic, and others. Some of its product offerings include Alergine, Kimoxil, Loprezol, Enkasari, and Batugin among others. It generates maximum revenue from the Retail segment.
58GF Score

Get the complete analysis for ISX:KAEF

Long-Term Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

Rp454.00
Price
Rp580.01
GF Value